- Home
- PRAX vs PRSU Comparison
PRAX vs PRSU Comparison
Compare PRAX & PRSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- PRSU
- Stock Information
- Founded
- PRAX 2015
- PRSU 1926
- Country
- PRAX United States
- PRSU United States
- Employees
- PRAX N/A
- PRSU N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- PRSU Business Services
- Sector
- PRAX Health Care
- PRSU Consumer Discretionary
- Exchange
- PRAX Nasdaq
- PRSU Nasdaq
- Market Cap
- PRAX 952.1M
- PRSU 999.2M
- IPO Year
- PRAX 2020
- PRSU N/A
- Fundamental
- Price
- PRAX $52.00
- PRSU $34.37
- Analyst Decision
- PRAX Strong Buy
- PRSU Strong Buy
- Analyst Count
- PRAX 10
- PRSU 3
- Target Price
- PRAX $93.30
- PRSU $29.67
- AVG Volume (30 Days)
- PRAX 435.3K
- PRSU 176.7K
- Earning Date
- PRAX 11-05-2025
- PRSU 11-15-2025
- Dividend Yield
- PRAX N/A
- PRSU N/A
- EPS Growth
- PRAX N/A
- PRSU 1138.43
- EPS
- PRAX N/A
- PRSU 9.98
- Revenue
- PRAX $7,765,000.00
- PRSU $382,378,000.00
- Revenue This Year
- PRAX N/A
- PRSU $22.00
- Revenue Next Year
- PRAX $20.00
- PRSU $8.35
- P/E Ratio
- PRAX N/A
- PRSU $3.46
- Revenue Growth
- PRAX 338.45
- PRSU 4.63
- 52 Week Low
- PRAX $26.70
- PRSU $26.66
- 52 Week High
- PRAX $91.83
- PRSU $47.49
- Technical
- Relative Strength Index (RSI)
- PRAX 56.68
- PRSU 40.42
- Support Level
- PRAX $46.99
- PRSU $34.96
- Resistance Level
- PRAX $55.86
- PRSU $36.56
- Average True Range (ATR)
- PRAX 3.62
- PRSU 0.90
- MACD
- PRAX 0.56
- PRSU -0.33
- Stochastic Oscillator
- PRAX 74.41
- PRSU 1.49
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About PRSU Pursuit Attractions and Hospitality Inc. Common Stock
Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.